An open label, two period, fixed sequence study evaluating the safety and pharmacokinetic interactions between elbasvir and the oral contraceptives ethinyl estradiol/levonorgestrel in healthy adult women

Trial Profile

An open label, two period, fixed sequence study evaluating the safety and pharmacokinetic interactions between elbasvir and the oral contraceptives ethinyl estradiol/levonorgestrel in healthy adult women

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Elbasvir (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Apr 2017 New trial record
    • 24 Feb 2017 Results from a pooled analysis from MK-5172-046 and MK-8742-013 studies, published in the European Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top